lobbying_activities: 3437929

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3437929	1871fdf2-134a-408d-9d2a-97f84a7ab0fc	Q3	DLA PIPER LLP (US)	76855	XEROX HOLDINGS CORPORATION (FORMERLY LEXMARK INTERNATIONAL, INC.)	2025	third_quarter	PHA	Ensuring full patient access to drug label and package insert information. H.R. 5133, Patients Right to Know Their Medication Act of 2025.	HOUSE OF REPRESENTATIVES,SENATE	60000		0	0	2025-10-16T16:12:11-04:00